Streamex Corp. (STEX)
| Market Cap | 116.71M-90.5% |
| Revenue (ttm) | 146.00K |
| Net Income | -500.84M |
| EPS | -9.04 |
| Shares Out | 116.47M |
| PE Ratio | n/a |
| Forward PE | -25.88 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 183,246 |
| Open | 0.57 |
| Previous Close | 0.53 |
| Day's Range | 0.52 - 0.57 |
| 52-Week Range | 0.48 - 6.50 |
| Beta | 2.02 |
| Analysts | none |
| Price Target | 4.00(+672.95%) |
| Earnings Date | Nov 12, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About STEX
Streamex Corp., a medical device technology company, provides advanced digital signal processing solutions for electrophysiology in the United States. The company offers the PURE EP platform, which delivers cardiac signal data to electrophysiologists during ablation procedures for the treatment of cardiovascular arrhythmias. It also develops and operates the Streamex Exchange platform, a blockchain-based platform that facilitates the tokenization and exchange of real-world assets for the tokenized gold market. In addition, the company offers software support, maintenance, and upgrade services. The company was formerly known as BioSig Technologies, Inc. and changed its name to Streamex Corp. in September 2025. Streamex Corp. was incorporated in 2009 and is headquartered in Winter Park, Florida.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$STEX stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in STEX holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by STEX's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
STEX Estimated quarterly lobbying spending
Source: U.S. Senate LDA
STEX Revenue by Segment
| Segment | Revenue | % of All |
|---|---|---|
| Realized gain on sale of gold | $2.94M | 76.79% |
| Change in fair value of embedded derivative | $497.00K | 12.99% |
| Realized (loss) gain on marketable securities | $377.00K | 9.85% |
| Change in fair value of marketable securities | $14.00K | 0.37% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New STEX patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to STEX from public contracts
Source: USAspending.gov
STEX Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from STEX’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score